Sigma

Angiotensin II human

A9525 -

≥93% (HPLC), powder

DOWNLOAD MSDS (PDF)
  • CAS Number: 4474-91-3

  • Empirical Formula (Hill Notation): C50H71N13O12

  • Molecular Weight: 1046.18

  • PubChem Substance ID: 24891466

Properties

Related CategoriesAngiotensins, Application Index, Cell Signaling Enzymes, Chymase and Related Products, Neuropeptides,
assay≥93% (HPLC)
formpowder
total impurities1.2-10.4% acetate
storage temp.−20°C
Gene InformationResearch your gene in Your Favorite Gene powered by Ingenuity
human ... AGT(183)

Description

Amino Acid Sequence

Asp-Arg-Val-Tyr-Ile-His-Pro-Phe

Antibody Adsorbant

Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH · 2CH3COOH · H2O

Analysis Note

Peptide content not less than 75%

Biochem/physiol Actions

Angiotensin (Ang) II is important in regulating cardiovascular hemodynamics and cardiovascular structure. Most of the known effects of Ang II in adult tissues are attributable to the angiotensin II type I (AT1) receptor. The AT1 and AT2 receptors have differential pharmacological and biochemical properties and appear to exert opposite effects in terms of cardiovascular hemodynamics and cell growth. In addition, the renin-angiotensin and nitric oxide-generating systems appear to interract in the regulation of cardiovascular function. Ang II stimulates angiogenesis and increases microvessel density. In nature, angiotensin II is produced by the action of angiotensin converting enzyme on angiotensinogen; the C-terminal-His-Leu is cleaved.

Price and Availability

Customers Also Purchased

powder, ≥98% (HPLC)

≥97% (HPLC), powder

analytical standard


Documents

Certificate of Analysis

Certificate of Origin

A9525 - Datasheet (80 KB)
Celltransmissions 19(1) (143 KB )
Angiotensin Receptors (178 KB )
Angiotensin Receptors (81 KB )
Neuropeptidases (252 KB)
Neuropeptidases Classification (197 KB )
Gene Information
Similar Products

Safety Information

Personal Protective EquipmentEyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
WGK Germany3
RTECSBW2165000
Technical information & documentation associated with this product is available in the Safety & Documentation tab.

Articles

Lipid Induced Insulin Resistance

Obesity is a well-established risk factor for the development of insulin resistance. Obesity is associated with the increased deposition of lipids in non-adipose tissue with subsequent decreases in i...
Linda Stephenson, Ph.D.
Biofiles v6 n4, 9
Keywords: Angiogenesis, Antivirals, Apoptosis, Biological processes, Cardiovascular, Catalog, Catalysis, Cell culture, Cell proliferation, Deposition, Diabetes, Gene expression, Growth factors, Hormones, Inflammation, Metabolism, Metabolites, Obesity, PAGE, Phosphorylations, Physiological Processes, Reductions, Transcription, Transduction

Plasma Derived Proteins and Enzymes

Despite their complexity, blood and plasma are abundant biological resources for the discovery of drug targets and biomarkers for human disease. It is estimated that plasma may contain as many as 40,...
BioFiles 2006, 1.5, 2.
Keywords: Gas chromatography

References

Inagami, T, et al., The renin-angiotensin system: an overview of its intracellular function. Cardiovasc. Drugs Ther. 2, 453-458, (1988) Abstract

Fernandez-Alfonso, M.S., and Gonzalez, C., Nitric oxide and the renin-angiotensin system. Is there a physiological interplay between the systems? J. Hypertens. 17, 1355-61, (1999) Abstract

Xoriuchi, M., et al., Cross talk between angiotensin II type 1 and type 2 receptors: cellular mechanism of angiotensin type 2 receptor-mediated cell growth inhibition. Hypertens. Res. 22, 67-74, (1999) Abstract

Inagami, T. et al., Angiotensin receptors: molecular biology and signaling. Clin. Exp. Pharmacol. Physiol. 26, 544-549, (1999) Abstract

Yongzhong, W., et al., Angiotnesin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J. Biol. Chem. 281, 35137-35146, (2006) Abstract

Takeshige, K., et al., Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation 114, 953-960, (2006) Abstract

Fan, H., et al., Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. Mol. Immunol. 44, 3092-9, (2007) Abstract

Yang, X., et al., Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation. J. Histochem. Cytochem. 26, 1629-35, (2008)

Sendra, J., et al., Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension. Carcinogenesis 78, 581-9, (2008)

Hauck, L., et al., Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart. Nat. Med. 14, 315-24, (2008) Abstract

DeWire, S.M., et al., Beta-arrestin-mediated signaling regulates protein synthesis. J. Bacteriol. 283, 10611-10620, (2008)

Hsu, H.H., et al., Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. J. Mol. Endocrinol. 86, 1379-94, (2008)

Zhao, Z.S., et al., Mouse hepatic portal venoconstrictive response to vasoconstrictors is much weaker than that in rat. J. Cardiovasc. Pharmacol. 54, 421-6, (2009) Abstract

Cheng, C., et al., Activation of MMP8 and MMP13 by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdown in atherosclerotic lesions with a vulnerable phenotype. Atherosclerosis 204, 26-33, (2009) Abstract

Xanthoulea, S., et al., Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice. PLoS Biol. 4, e6113, (2009)

Pelisch, N., et al., Systemic Candesartan Reduces Brain Angiotensin II Via Downregulation Of Brain Renin-angiotensin System. Hypertens. Res. 33, 161-4, (2010) Abstract

Rigel, D.F., et al., Pharmacodynamic And Pharmacokinetic Characterization Of The Aldosterone Synthase Inhibitor FAD286 In Two Rodent Models Of Hyperaldosteronism: Comparison With The 11beta-hydroxylase Inhibitor Metyrapone. J. Nutr. 334, 232-43, (2010)

Xanthoulea, S., et al., Absence Of P55 TNF Receptor Reduces Atherosclerosis, But Has No Major Effect On Angiotensin II Induced Aneurysms In LDL Receptor Deficient Mice. PLoS ONE 4, e6113, (2009) Abstract


Share your experience with this product and how it worked in your specific application. We value your opinion and your colleagues will too!

Learn more at www.sigmaaldrich.com/reviews.

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?